ABSTRACT
The integration of CAM raises considerable dilemmas regarding effectiveness within a medico-culture espousing EBM (Coulter, 2004), a professional body, which views much of the evidence available to back up CAM modalities as fundamentally flawed. However, huge public support and recent political pressure has meant that healthcare providers cannot afford to ignore the needs of patients above and beyond biomedical cancer care. Responses to such demands have been varied and large sections of UK cancer services remain largely biomedical in approach. However, others are attempting some degree of (albeit limited) integration. As a result, individual organisations are facing a plenitude of dilemmas, including the reassessment of traditional notions of evidence and effectiveness.
